Synta Pharma (SNTA) Tops Q1 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. MSFT
4. PLTR
5. META
6. JNJ
7. CSCO
8. KTOS
9. NVDA
10. QQQ

Go back to Synta Pharma (SNTA) Tops Q1 EPS by 1c

Synta Reports First Quarter 2015 Financial Results

May 7, 2015 7:00 AM EDT

- Webcast and Conference Call Today, May 7, at 10:00 AM ET -

LEXINGTON, Mass.--(BUSINESS WIRE)-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today reported financial results for the first quarter ended March 31, 2015 and provided an operational update.

We remain encouraged by the progress of our ganetespib clinical program including enrollment in our pivotal, Phase 3 GALAXY-2 trial in non-small cell lung adenocarcinoma, and the broad investigator-led trial effort, which includes large, ongoing randomized trials in acute myeloid leukemia and ovarian and breast cancers, said Chen Schor, President and Chief... More